Visikol, a leading drug discovery and bio-imaging service provider, relocated its entire operation to the Salem One Technology Complex in Whitehouse Station, New Jersey.

The new facility, which will encompass office, laboratory and manufacturing areas, will quadruple the company’s physical footprint and will be a key factor in supporting the defined growth and expansion plans currently in place, company officials said. In addition, the larger space will coincide with additional hires across all departments.

The new space recently underwent a Visikol directed refurbishment program lead by a leading life science contracting firm so that operational and management efficiencies can be immediately implemented.

“The decision to expand and relocate our entire operation was a simple one,” said company CEO Michael Johnson, “market conditions have dictated rapid growth in all areas of our organization and we needed to quickly expand our physical space to meet operational capacity. “

“We are excited to be in a much improved facility and we negotiated a lease agreement that substantially improved our per square foot cost and includes options for an additional 6,000 square feet of adjoining space so we are well positioned for future and immediate expansion,” he said.

Visikol is focused on accelerating drug discovery through quantitative histopathology and using its patented Visikol HISTO tissue clearing technology to transform tissues into three dimensional data sets that can be mined for actionable insights. The company said it continues to position it as the market leader in the emerging 3D imaging and quantitative image analysis market.